ANIMAL-FREE RIBOCICLIB OPTIONS ARE AVAILABLE.
Connect with our medical information pharmacists for more details.
 
Why you need to contact us:
Formulations are subject to change, so it's important to consult your healthcare provider or the manufacturer. Our VeganMed pharmacists are here to assist. Please note that our product information is general and not a substitute for professional medical advice. VeganMed does not assess safety or efficacy of medications.
 
Common Brand Name(s): Kisqali (200 mg daily-dose), Kisqali (400 mg daily-dose), Kisqali (600 mg daily-dose), Kisqali
Indication(s): 
Treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer
Drug Class: CDK 4/6 inhibitors